Frisch Financial Group, Inc.
Source: SEC Form 13F · as of Mar 2026Frisch Financial Group, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $19.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$19.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 42,505 | $10.4M |
| ABBVAbbVie Inc. | 7,546 | $1.6M |
| LLYELI LILLY & Co | 1,742 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,440 | $1.2M |
| MRKMerck & Co., Inc. | 9,239 | $1.1M |
| PFEPFIZER INC | 30,777 | $864K |
| ELVElevance Health Inc. | 1,900 | $556K |
| PMPhilip Morris International Inc | 3,150 | $525K |
| AMGNAMGEN INC | 1,377 | $484K |
| BMYBRISTOL MYERS SQUIBB CO | 4,690 | $284K |
| ABTABBOTT LABORATORIES | 2,636 | $271K |
| GERNGERON CORP | 19,025 | $28K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.